Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 1
1994 4
1995 3
1996 3
1997 5
1998 2
1999 5
2000 8
2001 8
2002 8
2003 7
2004 16
2005 9
2006 9
2007 11
2008 9
2009 11
2010 12
2011 21
2012 22
2013 31
2014 36
2015 28
2016 17
2017 27
2018 33
2019 27
2020 32
2021 22
2022 22
2023 15
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

409 results

Results by year

Filters applied: . Clear all
Page 1
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France.
Association française des centres d’addictovigilance; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. Association française des centres d’addictovigilance, et al. Among authors: lapeyre mestre m. Therapie. 2021 Jan-Feb;76(1):53-54. doi: 10.1016/j.therap.2020.01.001. Epub 2020 Jan 17. Therapie. 2021. PMID: 32005483 French. No abstract available.
Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?
Lapeyre-Mestre M, Sapède C, Moore N; les participants à la table ronde N° 5 de Giens XXVIII :; Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, Plétan Y, Pons G, Verpillat P, Vigneau C. Lapeyre-Mestre M, et al. Therapie. 2013 Jul-Aug;68(4):241-6. doi: 10.2515/therapie/2013037. Therapie. 2013. PMID: 27392726 French. No abstract available.
[Pharmacovigilance of self-medication].
Montastruc JL, Bagheri H, Geraud T, Lapeyre-Mestre M. Montastruc JL, et al. Among authors: lapeyre mestre m. Therapie. 1997 Mar-Apr;52(2):105-10. Therapie. 1997. PMID: 9231503 Review. French.
[Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
Moulis G, Lapeyre-Mestre M, Adoue D, Sailler L. Moulis G, et al. Among authors: lapeyre mestre m. Rev Med Interne. 2017 Jul;38(7):444-449. doi: 10.1016/j.revmed.2016.12.016. Epub 2017 Jan 26. Rev Med Interne. 2017. PMID: 28131440 Review. French.
Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.
Ollier N, Piel-Julian ML, Mahévas M, Viallard JF, Comont T, Chèze S, Audia S, Ebbo M, Terriou L, Lega JC, Jeandel PY, Bonnotte B, Michel M, Lapeyre-Mestre M, Godeau B, Moulis G. Ollier N, et al. Among authors: lapeyre mestre m. Blood. 2023 Sep 21;142(12):1099-1101. doi: 10.1182/blood.2023020311. Blood. 2023. PMID: 37478400 No abstract available.
Off-label and unlicensed drug use in children population.
Moulis F, Durrieu G, Lapeyre-Mestre M. Moulis F, et al. Among authors: lapeyre mestre m. Therapie. 2018 Apr;73(2):135-149. doi: 10.1016/j.therap.2018.02.002. Epub 2018 Feb 16. Therapie. 2018. PMID: 29580614 Review.
409 results